FAYDA ZAKARIA: Open Payments
NPI 1104896695 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 34 payments from 15 companies in 2025. Trend: 2023 $564 · 2024 $525 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $365 |
| PFIZER INC. | 5 | $93 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| Biogen, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Orexo US, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, NURTEC ODT, Cologuard Collection Kit, SKYCLARYS, REXULTI, Zubsolv, Veozah.
Industry payments across MI — which companies pay providers there.
